Report Categories
View AllRecent Articles
View All
Should I Buy Catalyst Cprx Stock Today Price At 24.69 Down 0.52 20260402
Market Recap SP 500 slips modestly as major indices pull back in cautious trade
Is Largo Inc LGO stock priced correctly Q1 2025 Earnings Fall Short
Is Advance Auto AAP stock a good opportunity today 082 20260420
OCCIO OFS Credit 6125 Series C preferred stock maintains quarterly distributions as management focuses on portfolio optimization
Gossamer Bio Faces Investor Lawsuit Deadline as Rosen Law Firm Urges Affected Shareholders to Act
SoFi Technologies Posts Strong Quarter but Softens Forward Guidance
US Labor Market Surpasses Expectations for Second Straight Month
Indias Parody Cockroach Party Claims Website Blocked Amid Digital Content Scrutiny
Jim Cramer Suggests Potential Buying Opportunity in VF Corporation
EVN Reports Q2 2026 Revenue Growth Despite Stock Decline
Backblaze BLZE Q1 2026 Earnings EPS Misses Estimates but Stock Gains 4 on Operational Momentum
MDCX Q1 2026 Earnings WiderthanExpected Losses as Stock Rises 548
AS Q1 2026 Earnings Strong EPS Beat Despite Muted Market Response
Kingsway Financial Services Q1 2026 Earnings Net Loss Reported Amid Quiet Market Response
KORE Q1 2026 Earnings Earnings Miss Estimates by Wide Margin Stock Reacts Modestly
VIPS Q4 2025 Earnings EPS Surprise Lifts Sentiment Amid Modest Stock Pullback
FIGS Inc Edges Higher as Stock Approaches Resistance Zone
Tevogen Bio Holdings Warrant TVGNW Stalls at 004 as Trading Remains Flat
Palmer Square Capital BDC PSBD Edges Higher as Price Nears Resistance Level
Soluna Holdings SLNH Surges Over 21 Key Levels to Watch After the Breakout
Sadot Group Inc SDOT Surges 6 as Buyers Test Key Resistance Near 321
Arcellx ACLX Q4 2025 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage
USPH Q1 2026 Earnings EPS Misses Estimates by 1725 but Stock Gains 332
eGain Corporation Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency
ALGT Q1 2026 Earnings EPS Surpasses Estimates by 1214
Telomir Pharmaceuticals Q4 2025 Earnings EPS Misses Wide Estimate as Development Costs Mount
Altimmune Q1 2026 Earnings Narrower Loss Surprises Amid Ongoing Clinical Focus